BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38501691)

  • 1. Assessment of Aspirin and Clopidogrel Resistance in Patients Undergoing Cardiovascular Surgery: A Single-Center Cross-Sectional Study.
    Özer A; Demirtaş H; Tak S; Koçak B; Yiğiter EN; Oktar GL; Kaya Z
    Turk J Haematol; 2024 May; 41(2):105-112. PubMed ID: 38501691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation.
    Van der Planken MG; Claeys MJ; Vertessen FJ; Dilling D; Bosmans JM; Berneman ZN; Michiels JJ; Vrints C
    Thromb Res; 2003; 111(3):159-64. PubMed ID: 14678814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
    Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients.
    Saunders J; Nambi V; Kimball KT; Virani SS; Morrisett JD; Lumsden AB; Ballantyne CM; Dong JF;
    J Vasc Surg; 2011 Mar; 53(3):668-75. PubMed ID: 21227624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
    Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional evaluation of platelet aspirin resistance after on-pump coronary bypass grafting using multiple aggregation tests.
    Kammerer I; Bach J; Saggau W; Isgro F
    Thorac Cardiovasc Surg; 2011 Oct; 59(7):425-9. PubMed ID: 21437867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of platelet function in acute ischemic stroke patients previously treated with aspirin.
    Lago A; Parkhutik V; Tembl JI; Vallés J; Santos MT; Moscardó A
    J Stroke Cerebrovasc Dis; 2014; 23(10):2794-2799. PubMed ID: 25440364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic kidney disease on platelet reactivity to dual-antiplatelet therapy in patients treated with drug-eluting stents.
    Arai T; Kawamura A; Matsubara Y; Yokoyama K; Ikeda Y; Fukuda K; Murata M
    Heart Vessels; 2012 Sep; 27(5):480-5. PubMed ID: 21837496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin non-responsiveness in Korean subjects on dual anti-platelet treatment determined by two different platelet function assays.
    Lee YW; Cho YH; Kim YH; Na JS; Shin HB; Ki CS; Choi TY; Lee YK
    Ann Clin Lab Sci; 2008; 38(2):126-31. PubMed ID: 18469357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients.
    Kotzailias N; Elwischger K; Sycha T; Rinner W; Quehenberger P; Auff E; Müller C
    J Stroke Cerebrovasc Dis; 2007; 16(5):199-202. PubMed ID: 17845916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy.
    Neubauer H; Kaiser AF; Endres HG; Krüger JC; Engelhardt A; Lask S; Pepinghege F; Kusber A; Mügge A
    BMC Med; 2011 Jan; 9():3. PubMed ID: 21226927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
    Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
    Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of acetylsalicylic acid and clopidogrel non-responsiveness assessed by light transmittance aggregometry and PFA-100® in patients undergoing neuroendovascular procedures.
    Rolling CC; Tomada J; Frölich AM; Holst B; Holstein K; Voigtländer M; Janjetovic S; Haddad M; Renné T; Fiehler J; Bokemeyer C; Rolling T; Langer F
    Clin Chem Lab Med; 2020 Aug; 59(2):383-392. PubMed ID: 32866112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
    Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable gender-dependent platelet responses to combined antiplatelet therapy in patients with stable coronary-artery disease.
    Jastrzebska M; Marcinowska Z; Oledzki S; Chelstowski K; Siennicka A; Klysz M; Clark JS
    J Physiol Pharmacol; 2018 Aug; 69(4):. PubMed ID: 30552303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro bleeding test with PFA-100-aspects of controlling individual acetylsalicylic acid induced platelet inhibition in patients with cardiovascular disease.
    Peters AJ; Borries M; Gradaus F; Jax TW; Schoebel FC; Strauer BE
    J Thromb Thrombolysis; 2001 Dec; 12(3):263-72. PubMed ID: 11981109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.